Key facts
- It has raised $28.0M; the latest was Early Stage VC ($14.3M) in Jan 2026.
- Notable investors include GF Xinde Investment Management, Huatai Zijin Investment, Noatic Bio-Medical, Tonghua Dongbao Pharmaceutical.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for InnoPac Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for InnoPac Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InnoPac Medical Technology
Developer of integrated containment and delivery systems intended for pharmaceutical and clinical use. The company offers automated manufacturing processes, customizable injection and transfer modules, and proprietary material engineering supported by a multidisciplinary R&D team, serving domestic and international healthcare manufacturers to achieve scalable production, regulatory compliance, and enhanced patient usability across a wide range of therapeutic applications.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- innopac.com/
- Ownership
- Privately Held (backing)
InnoPac Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InnoPac Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InnoPac Medical Technology in its N-PORT filings yet. We sweep new filings monthly.